Max Gerlach

497 total citations
19 papers, 353 citations indexed

About

Max Gerlach is a scholar working on Pulmonary and Respiratory Medicine, Management of Technology and Innovation and Physiology. According to data from OpenAlex, Max Gerlach has authored 19 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Management of Technology and Innovation and 4 papers in Physiology. Recurrent topics in Max Gerlach's work include Nitric Oxide and Endothelin Effects (3 papers), Product Development and Customization (2 papers) and Aviation Industry Analysis and Trends (2 papers). Max Gerlach is often cited by papers focused on Nitric Oxide and Endothelin Effects (3 papers), Product Development and Customization (2 papers) and Aviation Industry Analysis and Trends (2 papers). Max Gerlach collaborates with scholars based in Germany, United States and Canada. Max Gerlach's co-authors include Herwig Gerlach, Didier Keh, K. J. Falke, Katherine M. Kennedy, Deborah M. Sloboda, Markus M. Heimesaat, Thoralf Kerner, Thomas C. Adam, Laura Rossi and Thorsten Braun and has published in prestigious journals such as European Respiratory Journal, Intensive Care Medicine and Critical Care.

In The Last Decade

Max Gerlach

19 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Gerlach Germany 9 120 54 53 52 50 19 353
Daniel Rusu Romania 11 95 0.8× 118 2.2× 45 0.8× 47 0.9× 41 0.8× 24 411
Maristela Tsujita Brazil 11 96 0.8× 64 1.2× 115 2.2× 34 0.7× 22 0.4× 14 430
Stefan Büttner Germany 13 80 0.7× 50 0.9× 49 0.9× 97 1.9× 55 1.1× 31 434
Shoichiro Taniuchi Japan 12 83 0.7× 115 2.1× 78 1.5× 32 0.6× 68 1.4× 30 437
Masashi Uchida Japan 12 89 0.7× 34 0.6× 23 0.4× 56 1.1× 87 1.7× 63 477
Murilo Rezende Melo Brazil 13 131 1.1× 43 0.8× 41 0.8× 76 1.5× 39 0.8× 42 544
Diana Lebherz-Eichinger Austria 10 103 0.9× 50 0.9× 26 0.5× 66 1.3× 37 0.7× 17 337
Carlos Alberto Mayora Aita Brazil 12 119 1.0× 52 1.0× 20 0.4× 69 1.3× 31 0.6× 27 448
Irma Joosten Netherlands 11 130 1.1× 158 2.9× 47 0.9× 63 1.2× 35 0.7× 13 486

Countries citing papers authored by Max Gerlach

Since Specialization
Citations

This map shows the geographic impact of Max Gerlach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Gerlach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Gerlach more than expected).

Fields of papers citing papers by Max Gerlach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Gerlach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Gerlach. The network helps show where Max Gerlach may publish in the future.

Co-authorship network of co-authors of Max Gerlach

This figure shows the co-authorship network connecting the top 25 collaborators of Max Gerlach. A scholar is included among the top collaborators of Max Gerlach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Gerlach. Max Gerlach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kennedy, Katherine M., Max Gerlach, Thomas C. Adam, et al.. (2021). Fetal meconium does not have a detectable microbiota before birth. Nature Microbiology. 6(7). 865–873. 113 indexed citations
2.
Gerlach, Max, Theresia Kraft, Bernhard Brenner, et al.. (2018). Efficient Knock-in of a Point Mutation in Porcine Fibroblasts Using the CRISPR/Cas9-GMNN Fusion Gene. Genes. 9(6). 296–296. 21 indexed citations
3.
Gerlach, Max, Georg Jacobs, & Günther Schuh. (2016). Leistungsstaffelung in Produktprogrammen. RWTH Publications (RWTH Aachen). 1 indexed citations
4.
Gerlach, Max, Natalia Kliewer, & Catherine Cleophas. (2016). A note on effective code-share management in practice. Journal of Air Transport Management. 57. 202–205. 4 indexed citations
5.
Rebentisch, Eric, et al.. (2016). Determination of a Customer Value-oriented Product Portfolio. Procedia CIRP. 50. 82–87. 5 indexed citations
6.
Schuh, Günther, et al.. (2015). Schnittstellenmanagement in der Business-to-Business-Praxis. Zeitschrift für wirtschaftlichen Fabrikbetrieb. 110(11). 694–697. 1 indexed citations
7.
Schuh, Günther, et al.. (2015). Methodology for optimizing product differentiation in product ranges. 1541–1548. 3 indexed citations
8.
Gerlach, Max, Catherine Cleophas, & Natalia Kliewer. (2013). Airline Codeshare Alliances. Business & Information Systems Engineering. 5(3). 153–163. 7 indexed citations
9.
Gerlach, Max. (2013). Decentralized Code-Share Revenue Management in Airline Alliances. Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver. 2 indexed citations
10.
Gerlach, Max & Herwig Gerlach. (2002). Markers of hyperinflammation.. PubMed. 68(4). 252–6. 3 indexed citations
11.
12.
Haubitz, Marion, et al.. (2001). Endothelial tissue factor stimulation by proteinase 3 and elastase. Clinical & Experimental Immunology. 126(3). 584–588. 30 indexed citations
13.
Haubitz, Marion, Thilo Busch, Max Gerlach, et al.. (1999). Exhaled nitric oxide in patients with Wegener′s granulomatosis. European Respiratory Journal. 14(1). 113–113. 4 indexed citations
14.
Gerlach, Max, Didier Keh, G. Bezold, et al.. (1998). Nitric oxide inhibits tissue factor synthesis, expression and activity in human monocytes by prior formation of peroxynitrite. Intensive Care Medicine. 24(11). 1199–1208. 25 indexed citations
15.
Gerlach, Max, et al.. (1997). Global and Extended Coagulation Monitoring during Extracorporeal Lung Assist with Heparin-Coated Systems in ARDS Patients. The International Journal of Artificial Organs. 20(1). 29–36. 13 indexed citations
16.
Gerlach, Max, Didier Keh, Thoralf Kerner, et al.. (1997). Peroxynitrite reduces endotoxin-induced tissue factor expression in human peripheral blood monocytes. Critical Care. 1(Suppl 1). P023–P023. 1 indexed citations
17.
Keh, Didier, Max Gerlach, Steven M. Seiler, et al.. (1996). The effects of nitric oxide (NO) on platelet membrane receptor expression during activation with human ??-thrombin. Blood Coagulation & Fibrinolysis. 7(6). 615–624. 30 indexed citations
18.
Keh, Didier, et al.. (1996). Reduction of Platelet Trapping in Membrane Oxygenators by Transmembraneous Application of Gaseous Nitric Oxide. The International Journal of Artificial Organs. 19(5). 291–293. 19 indexed citations
19.
Gerlach, Herwig, et al.. (1993). Relevance of tumour necrosis factor-alpha and interleukin-1-alpha in the pathogenesis of hypoxia-related organ failure.. PubMed. 10(4). 273–85. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026